JCR Pharmaceuticals Co. Ltd.

JCR Pharmaceuticals, founded 1975, specializes in high‑value biologics in Japan, producing GROWJECT, Agalsidase Beta BS, TEMCELL HS, and renal anemia biosimilars. It exports medicines, partners on CNS gene therapy, positioning for growth in rare‑disease and biosimilar markets.

Headquarters: Japan (JPN)

JCR Pharmaceuticals Co. Ltd. Logo
Company Profile
  • Employees: 987
  • HQ: Ashiya
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
4552 JCR Pharmaceuticals Co. Ltd.
Cap: 84.8B
EQUITY JPX JPY JP3701000006 Active
📈
Home Login